Let-7g reverses malignant phenotype of osteosarcoma cells by targeting Aurora-B

Jia Ming Liu1, Xin Hua Long1, Guo Mei Zhang2

  • 1Department of Orthopedics, The First Affiliated Hospital of Nanchang University Jiangxi, China.

Insights

MicroRNAs let-7g are down-regulated in osteosarcoma (OS), inhibiting cancer cell growth by targeting the oncogene Aurora-B. Restoring let-7g or inhibiting Aurora-B may offer new therapeutic strategies for OS.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Osteosarcoma (OS) exhibits altered microRNA (miRNA) expression profiles.
  • let-7g is a miRNA with potential roles in tumor suppression.
  • Aurora-B is an oncogene frequently overexpressed in OS.

Purpose of the Study:

  • To investigate the functional role of let-7g in OS cells.
  • To identify molecular targets of let-7g in OS.
  • To explore therapeutic potential of targeting let-7g and Aurora-B in OS.

Main Methods:

  • Quantitative real-time PCR to assess let-7g expression.
  • Bioinformatic analysis to predict let-7g targets.
  • Western blotting and luciferase assays to validate let-7g-Aurora-B interaction.
  • Cell viability, apoptosis, migration, and invasion assays to evaluate functional effects.

Main Results:

  • let-7g expression was significantly downregulated in OS cell lines (U2-OS, HOS) compared to normal osteoblast cells (HOB).
  • Aurora-B was identified as a direct target gene of let-7g in OS cells.
  • Restoration of let-7g or silencing of Aurora-B suppressed OS cell viability, migration, and invasion, while inducing apoptosis.
  • Silencing Aurora-B partially reversed the tumor-promoting effects of anti-let-7g activity.

Conclusions:

  • let-7g functions as a tumor suppressor in osteosarcoma by targeting Aurora-B.
  • The let-7g/Aurora-B axis plays a crucial role in regulating OS cell malignancy.
  • Targeting let-7g and Aurora-B represents a potential novel therapeutic strategy for osteosarcoma treatment.